NORDEA INVESTMENT MANAGEMENT AB - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORDEA INVESTMENT MANAGEMENT AB ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,114,202
-45.0%
640,346
-4.9%
0.00%
-33.3%
Q4 2022$2,026,928
-40.9%
673,398
-1.3%
0.00%
-50.0%
Q3 2022$3,428,000
+25.2%
682,112
+0.1%
0.01%
+50.0%
Q2 2022$2,738,000
-30.5%
681,112
+5.0%
0.00%
-20.0%
Q1 2022$3,942,000
-18.5%
648,430
+5.4%
0.01%
-16.7%
Q4 2021$4,837,000
-17.2%
615,442
-1.8%
0.01%
-25.0%
Q3 2021$5,839,000
-23.5%
626,496
-1.8%
0.01%
-20.0%
Q2 2021$7,636,000
+6.7%
637,890
+9.9%
0.01%0.0%
Q1 2021$7,159,000
-18.2%
580,168
+3.5%
0.01%
-28.6%
Q4 2020$8,748,000
+166.5%
560,588
+68.6%
0.01%
+133.3%
Q3 2020$3,282,000
-43.7%
332,511
-49.6%
0.01%0.0%
Q2 2020$5,834,000
+177.0%
660,048
+103.4%
0.01%
+20.0%
Q1 2020$2,106,000
-19.8%
324,506
+2.4%
0.01%0.0%
Q4 2019$2,625,000
-4.3%
317,002
+5.5%
0.01%
-16.7%
Q3 2019$2,743,000
-14.6%
300,393
+0.7%
0.01%
-14.3%
Q2 2019$3,213,000
+9.1%
298,267
-3.4%
0.01%
+16.7%
Q1 2019$2,946,000
-72.9%
308,717
-67.4%
0.01%
-33.3%
Q4 2018$10,875,000
+0.9%
947,061
+48.9%
0.01%
-18.2%
Q3 2018$10,778,000
+295.2%
635,838
+231.1%
0.01%
+57.1%
Q2 2018$2,727,000
+19.3%
192,016
+59.6%
0.01%
+40.0%
Q1 2018$2,286,000120,2930.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 6,000,000$66,540,0006.69%
FIC CAPITAL INC 787,529$8,734,0003.47%
RA Capital Management 1,220,209$13,532,0001.36%
PRINCETON CAPITAL MANAGEMENT INC 114,120$1,266,0000.67%
Perceptive Advisors 800,000$8,872,0000.53%
Cormorant Asset Management, LP 361,000$4,003,0000.53%
Highlander Capital Management, LLC 43,500$482,0000.43%
APEX CAPITAL, LLC 439,900$4,878,0000.42%
WASATCH ADVISORS LP 3,091,386$34,283,0000.37%
Baker Brothers Advisors 3,230,932$35,831,0000.31%
View complete list of SANGAMO THERAPEUTICS INC shareholders